Perioperative Polmacoxib Reduce Opioid Consumption for Post Operative Pain After Rotator Cuff Tear.

Launched by EULJI UNIVERSITY HOSPITAL · Sep 6, 2024

Keywords

ClinConnect Summary

This clinical trial is studying whether a medication called Polmacoxib can help reduce the need for opioid pain medication after surgery for a rotator cuff tear. The trial aims to see if taking Polmacoxib before and after surgery can help manage pain more effectively while using fewer opioids, which can have side effects and lead to dependency.

To be eligible for the trial, participants must be over 18 years old and require rotator cuff surgery due to identified issues like arthritis. They should not have taken non-steroidal anti-inflammatory drugs (NSAIDs) or a pain medication called Ultracet for at least a month before the study. Participants will receive either the Polmacoxib treatment or standard pain relief, and their pain levels and medication use will be monitored for three months after surgery. The trial is currently recruiting participants, and anyone interested should discuss it with their doctor to see if they qualify.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients over 18 years of age
• • Patients who need rotator cuff rupture or rotator cuff surgery with MRI identified osteoarthritis (especially small and medium SST dominant rupture)
• • NSAIDs unadministered patients for more than 1 month
• • Ultracet unadministered patients for more than 1 month
• Exclusion Criteria:
• • primary fiftieth shoulder
• • including short-lived frozen shoulders
• • infectious arthritis
• • previous corticosteroid injections/surgery
• • moderate-severe arthroplasty
• • a traumatized patient
• • a central or peripheral nervous system disease
• • a mental illness that may not conform to medical or physical therapy
• • a woman of childbearing age
• • Pregnancy
• • a severe gastrointestinal ulcer